Navigation Links
.decimal, Inc. Gains 510k Clearance from the FDA to Market its p.d(TM) Software for Bolus Electron Conformal Therapy in the United States
Date:5/11/2009

SANFORD, Fla., May 11 /PRNewswire/ -- .decimal, leading manufacturer of patient-specific medical devices, gains 510k clearance to release the software necessary for the delivery of Bolus Electron Conformal Therapy (Bolus ECT(TM)), an advanced form of patient-specific electron therapy. Treating with bolus ECT will be available to users of all three of the major treatment planning systems: CMS XiO(TM), Varian Eclipse(TM) and Philips Pinnacle3(TM).

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

510k clearance to market the device makes it possible for cancer treatment centers in the United States to begin ordering, installing and using .decimal's propriety software, p.d, for bolus ECT. "We are now actively marketing bolus electron conformal therapy, and the response from institutions across the United States has been overwhelming as they begin to see the value to their patients through this innovative technology," says Mark Mills, Senior Vice President of Sales and Marketing at .decimal.

.decimal is the sole manufacturer of the bolus, as well as the sole software provider for bolus ECT planning.

Richard Sweat, President and CEO of the company explains, "The commercial availability of bolus electron conformal therapy is another example of our commitment to providing our customers with innovative treatment solutions and their patients with the best individualized electron treatment available in the world."

Bolus ECT can create favorable dose distributions for certain tumors of the chest wall, breast or head and neck, when a tumor volume has spread out near the patient surface and rendered other treatment problematic for a variety of reasons. Bolus ECT was first used at the University of Texas M.D. Anderson Cancer Center over ten years ago, but did not become commercially available until this software release.

"With this product we are enabling the 80% of radiation oncology facilities in the United States treating with electrons the opportunity to enhance their current electron delivery capabilities through our unique pay-as-you-go, Internet-based manufacturing business model," says Sweat.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced IMRT delivery, bolus compensators for bolus electron conformal therapy, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
2. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
3. Grey Ribbon Crusade(TM) Promotes National Unification in the Fight Against Brain Tumors
4. Obama Administration Rules Against Californias Proposed Wage Cuts to Homecare Workers
5. NABP Position Paper Calls for Action Against Proliferation of Rogue Internet Drug Outlets
6. Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture
7. Research opens up new horizons to the design of customized medicines against breast cancer
8. Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1
9. Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1
10. Federal District Judge Dismisses Antitrust Lawsuit Against Batesville Casket Company
11. Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: